Autoimmune Diseases  >>  tacrolimus intravenous  >>  Phase 3
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tacrolimus intravenous / Generic mfg.
NCT00036153: Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

Completed
3
210
US, Canada
Tacrolimus (Prograf®), Methotrexate
Astellas Pharma Inc, Astellas Pharma US, Inc.
Rheumatoid Arthritis
 
01/04
NCT00309088: FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

Completed
3
80
Japan
tacrolimus, Prograf, FK506, placebo
Astellas Pharma Inc
Myasthenia Gravis
06/08
06/08
NCT00309101: An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

Completed
3
11
Japan
tacrolimus, FK506, Prograf
Astellas Pharma Inc
Myasthenia Gravis
02/09
02/09
NCT01342016: A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients

Terminated
3
84
RoW
tacrolimus capsule, prograf, FK506, tacrolimus placebo, leflunomide tablet, airuohua, leflunomide placebo, prednisone
Astellas Pharma Inc, Astellas Pharma China, Inc.
Lupus Nephritis
05/13
05/13
NCT01325571: A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

Completed
3
83
RoW
Tacrolimus capsule, Prograf, FK506, Placebo
Astellas Pharma Inc, Astellas Pharma China, Inc.
Myasthenia Gravis
05/14
05/14

Download Options